Testing effectiveness (Phase 2)Study completedNCT05041062
What this trial is testing
Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma
Who this might be right for
MesotheliomaPeritoneal Mesothelioma
University of Chicago 2